Kukjeon

(주)국전 · KOSDAQ · 307750 · Industry: Manufacture of medicaments

Key metrics

Earnings

Revenue, Q3 2026₩31.3bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-22.7% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+7.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩676m As of Sep 30, 2026 Source 1 ↗
Operating income QoQTurned to loss As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY+66.7% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩17.0bn As of Oct 23, 2026 Source 1
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months6,305,637 shares As of Oct 23, 2026 Source 1
Potential new shares, % of shares11.7% As of Oct 23, 2026 Source 1, Source 2 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months5 As of Nov 19, 2026
DART filings, previous 3 months10 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Jul 21, 2026Hong Jong-hun (Registered director)Other (Gift given)-50,000 shares——
Jul 21, 2026Hong Jong-hun (Registered director)Other (Gift given)-50,000 shares——
Jul 16, 2026Hong Jong-hun (Registered director)Other+139,630 shares——

Annual financials

YearRevenueOperating income
2025₩131.0bn-₩2.6bn
2024₩136.5bn₩368m
2023₩122.0bn₩6.5bn

Filing timeline